Efficacy of Parecoxib on Patients With CRPS

Causalgia Clinical Trial

Official title:
Efficiacy of the Selctive COX-2-inhibitor Parecoxibe on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS)

Status No longer available

Clinical Trial Summary

The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01523379
Study type	Expanded Access
Source	Ruhr University of Bochum
Contact
Status	No longer available
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02667717` - Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy	N/A
Recruiting	`NCT06306157` - Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome	Phase 4
Completed	`NCT03954080` - Trialing of ISS in Patients With CRPS	N/A
Terminated	`NCT01088256` - Efficacy of Etoricoxib on Peripheral Hyperalgesia	Phase 2